BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on PD-L11/VEGF-A ...
CES Energy Solutions Corp. ("CES" or the "Company") (TSX: CEU) (OTC: CESDF) is pleased to announce record financial results for the three and twelve months ended December 31, 2025, along with a 29% ...
C3.ai, Inc. AI reported third-quarter fiscal 2026 results that reflected operational challenges alongside ongoing enterprise AI deployments. During the quarter, revenues totaled $53.3 million, missing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results